Correlation of Tumor Volume and Surface Area with Lymph Node Status in Patients with Multifocal/Multicentric Breast Carcinoma

Cancer

Volumn 100, Issue 1, 2004, Pages 20-27

  Andea, Aleodor A ^a   Bouwman, David ^b   Wallis, Tracie ^b   Visscher, Daniel W ^c  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MAYO CLINIC   (United States)

Author keywords

Axillary lymph node metastasis; Breast carcinoma; Multicentric; Multifocal

Indexed keywords

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BODY SURFACE; BREAST CARCINOMA; CANCER SIZE; CELL TYPE; CORRELATION ANALYSIS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; ANTHROPOMETRY; AXILLA; BREAST NEOPLASMS; CARCINOMA; FEMALE; HUMANS; LYMPHATIC METASTASIS; MIDDLE AGED; MODELS, THEORETICAL; NEOPLASMS, SECOND PRIMARY; PROGNOSIS;

EID: 0346217064     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.11880     Document Type: Article

References (44)

1. Carter CL, Allen C, Henson DE. Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer. 1989;63:181-187.
2. Laroye GJ, Panzarella T. Two techniques for measuring invasion in solid tumors. Evaluated in a retrospective study of 73 cases of breast carcinoma with 10-year follow-up. APMIS. 1994;102:103-111.
3. Koscielny S, Tubiana M, Le MG, et al. Breast cancer: relationship between the size of the primary tumour and the probability of metastatic dissemination. Br J Cancer. 1984;49:709-715.
4. Sivaramakrishna R, Gordon R. Detection of breast cancer at a smaller size can reduce the likelihood of metastatic spread: a quantitative analysis. Acad Radiol. 1997;4:8-12.
5. Fisher B, Slack NH, Bross ID. Cancer of the breast: size of neoplasm and prognosis. Cancer. 1969;24:1071-1080.
6. Valagussa P, Bonadonna G, Veronesi U. Patterns of relapse and survival following radical mastectomy. Analysis of 716 consecutive patients. Cancer. 1978;41:1170-1178.
7. Smart CR, Myers MH, Gloeckler LA. Implications from SEER data on breast cancer management. Cancer. 1978;41:787-789.
8. Fehr MK, Kochli OR, Helfenstein U, et al. [Multivariate analysis of clinico-pathologic predictors of axillary lymph node metastasis in invasive breast carcinoma]. Geburtshilfe Frauenheilkd. 1995;55:182-188.
9. Michaelson JS, Halpern E, Kopans DB. Breast cancer: computer simulation method for estimating optimal intervals for screening. Radiology. 1999;212:551-560.
10. Michaelson JS, Silverstein M, Wyatt J, et al. Predicting the survival of patients with breast carcinoma using tumor size. Cancer. 2002;95:713-723.
11. Lesser ML, Rosen PP, Kinne DW. Multicentricity and bilaterality in invasive breast carcinoma. Surgery. 1982;91:234-240.
12. Fish EB, Chapman JA, Link MA. Assessment of tumor size for multifocal primary breast cancer. Ann Surg Oncol. 1998;5:442-446.
13. Andea AA, Wallis T, Newman LA, Bouwman D, Dey J, Visscher DW. Pathologic analysis of tumor size and lymph node status in multifocal/multicentric breast carcinoma. Cancer. 2002;94:1383-1390.
14. Vlastos G, Rubio IT, Mirza NQ, et al. Impact of multicentricity on clinical outcome in patients with T1-2, NO-1, MO breast cancer. Ann Surg Oncol. 2000;7:581-587.
15. Fowble B, Yeh IT, Schultz DJ, et al. The role of mastectomy in patients with stage I-II breast cancer presenting with gross multifocal or multicentric disease or diffuse microcalcifications. Int J Radiat Oncol Biol Phys. 1993;27:567-573.
16. Brenin DR, Morrow M. Accuracy of AJCC staging for breast cancer patients undergoing re-excision for positive margins. American Joint Committee on Cancer. Ann Surg Oncol. 1998;5:719-723.
17. Egan RL. Multicentric breast carcinomas: clinical-radiographic-pathologic whole organ studies and 10-year survival. Cancer. 1982;49:1123-1130.
18. Fleming ID, Cooper JS, Hensen DE, et al., editors. AJCC cancer staging manual. 5th ed. Philadelphia: Lippincott-Raven, 1998.
19. Sobin LH, Wittwkind C, editors. TNM classification of malignant tumors. 5th ed. New York: John Wiley & Sons, 1997.
20. Sobin LH, Wittwkind C, editors. TNM classification of malignant tumours. 6th ed. New York: John Wiley & Sons, 2002.
21. Kleinbaum DG. Logistic regression: a self-learning text. New York: Springer, 1994.
22. Fisher ER, Gregorio R, Redmond C, Vellios F, Sommers SC, Fisher B. Pathologic findings from the National Surgical Adjuvant Breast Project (protocol no. 4). I. Observations concerning the multicentricity of mammary cancer. Cancer. 1975;35:247-254.
23. Dawson PJ. What is new in our understanding of multifocal breast cancer. Pathol Res Pract. 1993;189:111-116.
24. Dawson PJ. Bilateral and multifocal breast cancer. Cancer Control. 1996;3:258-266.
25. Sarnelli R, Squartini F. Multicentricity in breast cancer: a submacroscopic study. Pathol Annu. 1986;21:143-158.
26. Westman-Naeser S, Bengtsson E, Eriksson O, Jarkrans T, Nordin B, Stenkvist B. Multifocal breast carcinoma. Am J Surg. 1981;142:255-257.
27. Vaidya JS, Vyas JJ, Chinoy RF, Merchant N, Sharma OP, Mittra I. Multicentricity of breast cancer: whole-organ analysis and clinical implications. Br J Cancer. 1996;74:820-824.
28. Anastassiades O, Iakovou E, Stavridou N, Gogas J, Karameris A. Multicentricity in breast cancer. A study of 366 cases. Am J Clin Pathol. 1993;99:238-243.
29. Gump FE. Multicentricity in early breast cancer. Semin Surg Oncol. 1992;8:117-121.
30. Holland R, Veling SH, Mravunac M, Hendriks JH. Histologic multifocality of Tis, T1-2 breast carcinomas. Implications for clinical trials of breast-conserving surgery. Cancer. 1985;56:979-990.
31. Luttges J, Kalbfleisch H, Prinz P. Nipple involvement and multicentricity in breast cancer. A study on whole organ sections. J Cancer Res Clin Oncol. 1987;113:481-487.
32. Otto R, Engeler V. [The problem of the multifocal breast neoplasm]. Schweiz Med Wochenschr. 1979;109:752-757.
33. Schwartz GF, Patchefsky AS, Feig SA, Shaber GS, Schwartz AB. Clinically occult breast cancer. Multicentricity and implications for treatment. Ann Surg. 1980;191:8-12.
34. Le Doussal V, Tubiana-Hulin M, Friedman S, Hacene K, Spyratos F, Brunet M. Prognostic value of histologic grade nuclear components of Scarff-Bloom-Richardson (SBR). An improved score modification based on a multivariate analysis of 1262 invasive ductal breast carcinomas. Cancer. 1989;64:1914-1921.
35. Pinder SE, Murray S, Ellis IO, et al. The importance of the histologic grade of invasive breast carcinoma and response to chemotherapy. Cancer. 1998;83:1529-1539.
36. Davis BW, Gelber RD, Goldhirsch A, et al. Prognostic significance of tumor grade in clinical trials of adjuvant therapy for breast cancer with axillary lymph node metastasis. Cancer. 1986;58:2662-2670.
37. Clayton F, Hopkins CL. Pathologic correlates of prognosis in lymph node-positive breast carcinomas. Cancer. 1993;71:1780-1790.
38. Wong JS, O'Neill A, Recht A, et al. The relationship between lymphatic vessell invasion, tumor size, and pathologic nodal status: can we predict who can avoid a third field in the absence of axillary dissection? Int J Radiat Oncol Biol Phys. 2000;48:133-137.
39. Pereira H, Pinder SE, Sibbering DM, et al. Pathological prognostic factors in breast cancer. IV: Should you be a typer or a grader? A comparative study of two histological prognostic features in operable breast carcinoma. Histopathology. 1995;27:219-226.
40. Davis BW, Gelber R, Goldhirsch A, et al. Prognostic significance of peritumoral vessel invasion in clinical trials of adjuvant therapy for breast cancer with axillary lymph node metastasis. Hum Pathol. 1985;16:1212-1218.
41. Fisher ER, Gregorio RM, Fisher B, Redmond C, Vellios F, Sommers SC. The pathology of invasive breast cancer. A syllabus derived from findings of the National Surgical Adjuvant Breast Project (protocol no. 4). Cancer. 1975;36:1-85.
42. Bettelheim R, Penman HG, Thornton-Jones H, Neville AM. Prognostic significance of peritumoral vascular invasion in breast cancer. Br J Cancer. 1984;50:771-777.
43. Weigand RA, Isenberg WM, Russo J, Brennan MJ, Rich MA. Blood vessel invasion and axillary lymph node involvement as prognostic indicators for human breast cancer. Cancer. 1982;50:962-969.
44. Roses DF, Bell DA, Flotte TJ, Taylor R, Ratech H, Dubin N. Pathologic predictors of recurrence in stage 1 (TINOMO) breast cancer. Am J Clin Pathol. 1982;78:817-820.